Skip to content

Effect of Olea ointment on burn wounds

Assessing the effect of Olea ointment (a compound of honey, olive, and sesame) on infection and granulation tissue formation in second degree burn wounds - A randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014020516490N1
Enrollment
30
Registered
2014-04-11
Start date
2005-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. Burn of second degree of shoulder and upper limb, except wrist and hand

Interventions

Intervention 1: Intervention group 1 was consisted of 10 patients who were treated using Olea ointment (manufactured in Farateb Co. Iran). Olea ointment contains 33.4% honey, 33.3% olive oil and 33.3%
they were treated using 1-2 mm thick of Acetate Mafenide ointment (8.5%, manufactured by Sina Daro pharmaceutical company, Iran) over the wound.
Treatment - Drugs
Intervention group 1 was consisted of 10 patients who were treated using Olea ointment (manufactured in Farateb Co. Iran). Olea ointment contains 33.4% honey, 33.3% olive oil and 33.3% Sesame oil. Aft
The intervention group 2 was consisted of 20 patients

Sponsors

Vice chancellor for research, Kurdistan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who had second degree burns (burn depth of 0.2 to 5.0 mm); burns covered 40% or less of their body surface area; were aged between 15 to 40 years; consented to participate in the study; referred at the first 24 hours of injury; and had negative ulcer culture on admission. Exclusion criteria: patients with underlying conditions such as diabetes; chronic renal or hepatic diseases, and patients with simultaneous burns, trauma, and skin lacerations.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wound infection. Timepoint: A week after intervention. Method of measurement: Culture.

Secondary

MeasureTime frame
Situation of granulation tissues formation. Timepoint: A week after intervention. Method of measurement: Pathology.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRonak Babashahabi

Tohid Hospital, Kurdistan University of Medical Sciences

roonak_sh@hotmail.com+98 87 1666 0092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026